Different types of skin cancers.Risk Factors,prevention,early detection of skin cancers in 10marks format for 3rd yr dermatology post graduate examination

Reading File

Finding Sources

Searching PubMed

"skin cancer" AND "early detection" AND prevention

Finding Sources

Reading File

Finding Sources

Reading File

Searching Images

types of skin cancer basal cell carcinoma squamous cell carcinoma melanoma clinical appearance

I now have comprehensive content from Fitzpatrick's Dermatology and other authoritative textbooks. Let me compile the complete 10-marks postgraduate examination answer.

Skin Cancers: Types, Risk Factors, Prevention & Early Detection

A 10-Mark PG Dermatology Examination Answer

INTRODUCTION

Skin cancers are the most common human malignancies. They are broadly classified into melanoma and non-melanoma skin cancers (NMSC), the latter comprising basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Early detection dramatically improves prognosis, especially for melanoma.

I. TYPES OF SKIN CANCERS

1. Basal Cell Carcinoma (BCC)

The most common human malignancy — >2 million cases/year in the USA alone. Arises from interfollicular basal cells of the epidermis. Rarely metastasizes but causes significant local destruction. Lifetime risk in Caucasians is ~1 in 5.

Clinical subtypes:

Subtype	Features
Nodular BCC (most common)	Pink pearly papule/nodule, central depression/ulceration, rolled borders with telangiectasias
Superficial BCC	Pink-red erythematous patch, mildly raised plaque; fine scale; seen on trunk/back
Morpheiform/Sclerosing BCC	Scar-like, indurated plaque; ill-defined margins; most aggressive; subclinical extension common
Pigmented BCC	Contains melanin; may mimic melanoma; pearly nodule with pigmentation
Micronodular/Infiltrating BCC	High-risk histology; requires wide margins (5–10 mm) for clearance

Preferred sites: Face (nose, eyelids, temples — "H-zone"), ears, scalp, neck, upper trunk.

2. Squamous Cell Carcinoma (SCC)

Second most common NMSC. Arises from epidermal keratinocytes. Greater metastatic potential than BCC (~5%), especially on lip and ear.

Clinical subtypes:

Subtype	Features
Actinic Keratosis (precursor)	Rough, scaly, erythematous macule/papule on sun-exposed skin; ~10% progress to invasive SCC
SCC in situ (Bowen's disease)	Full-thickness epidermal dysplasia; well-demarcated erythematous scaly plaque
Invasive SCC	Hyperkeratotic, crusted, elevated nodule with central ulceration; indurated base
Verrucous carcinoma	Exophytic warty growth; low-grade malignancy
Keratoacanthoma	Rapidly growing, crater-like lesion with keratin plug; controversial – may regress spontaneously

High-risk features: >2 cm diameter, poorly differentiated histology, perineural invasion, lip/ear location, immunosuppression, recurrent lesion.

3. Melanoma (Malignant Melanoma)

Most lethal skin cancer — causes >77% of skin cancer deaths. Arises from melanocytes at the dermo-epidermal junction. Almost half develop in pre-existing nevi; the rest on previously normal-appearing skin.

Clinicopathologic Subtypes:

Subtype	Frequency	Features
Superficial Spreading Melanoma (SSM)	60–70%	Most common; trunk and legs; prolonged radial growth phase; ABCDE features prominent
Nodular Melanoma (NM)	15–30%	Solid black/blue-black; rapid vertical growth; thickest at presentation; worst prognosis
Lentigo Maligna Melanoma (LMM)	5–15%	Elderly patients; face/sun-damaged skin; slow-growing tan-brown macule; arises in Hutchinson's melanotic freckle
Acral Lentiginous Melanoma (ALM)	5–10%	Palms, soles, subungual; most common in Asians and dark-skinned individuals; associated with KIT gene mutations
Desmoplastic Melanoma	Rare	Amelanotic, fibrous; high rate of local recurrence; predilection for perineural invasion
Mucosal Melanoma	Rare	Oral, genital, anorectal; poor prognosis

Key molecular associations:

BRAF mutations: SSM on non-chronically sun-exposed skin in Caucasians
KIT mutations & Cyclin D1/CDK4 amplification: ALM and mucosal melanoma
p16/CDKN2A mutation: familial melanoma

4. Other Cutaneous Malignancies

Merkel Cell Carcinoma — neuroendocrine; aggressive; associated with Merkel Cell Polyomavirus; elderly/immunosuppressed
Dermatofibrosarcoma Protuberans (DFSP) — locally aggressive; rare metastasis; fibroblastic origin
Cutaneous T-cell Lymphoma (Mycosis Fungoides) — patch → plaque → tumor stage; exquisitely radiosensitive
Kaposi Sarcoma — vascular; HHV-8 associated; HIV/immunosuppressed patients
Sebaceous Carcinoma — periocular region; associated with Muir-Torre syndrome

II. RISK FACTORS

A. Non-Modifiable Risk Factors

Factor	BCC/SCC	Melanoma
Fitzpatrick skin type I–II (fair skin, blue eyes, red/blond hair)	✔	✔
Positive family history	✔	✔ (10× risk with first-degree relative)
Personal history of skin cancer	✔ (30% risk of second BCC)	✔
Age >65 years	✔	✔
Male sex	✔	✔
Xeroderma pigmentosum	✔	✔
Gorlin syndrome (PTCH1 mutation)	✔ BCC	—
p16/CDKN2A, CDK4 mutation	—	✔
>100 melanocytic nevi or atypical nevi	—	✔
Giant congenital nevus (>20 cm)	—	✔ (5–8% lifetime risk)

B. Modifiable/Environmental Risk Factors

Ultraviolet radiation (UV-B primary; UV-A via PUVA/tanning beds): Most critical risk factor for all three major types. Induces cyclobutane pyrimidine dimers and p53 mutations
Blistering sunburns in childhood (>3 episodes) — strongly associated with melanoma
Tanning beds — 75% increased melanoma risk if used before age 35
Chronic UV exposure (cumulative) — BCC and SCC
Ionising radiation — post-radiation BCC/SCC in treatment fields
Chemical carcinogens: Arsenic (Bowen's disease, SCC), tar, coal, petroleum products
HPV infection: Epidermodysplasia verruciformis → SCC (HPV 5, 8); genital/perianal SCC (HPV 16, 18)
Immunosuppression: Organ transplant recipients — 5–10× BCC risk; 65× SCC risk; tend to be more aggressive
Chronic wounds/scars: Marjolin's ulcer — SCC arising in burn scars, venous ulcers, osteomyelitis sinuses
PUVA therapy — cumulative risk of SCC; melanoma with high-dose exposure
Inflammatory conditions: Lichen sclerosus, lupus vulgaris, discoid lupus → SCC risk

III. PREVENTION

Primary Prevention

1. Sun Protection

Broad-spectrum sunscreen (SPF ≥30, UVA+UVB) — daily application to all sun-exposed areas; reapply every 2 hours and after swimming/sweating
Protective clothing: UPF-rated clothing, wide-brimmed hats (>7.5 cm brim), UV-blocking sunglasses
Behavioural modification: Avoid peak UV hours (10 AM – 4 PM); seek shade
Avoid tanning beds and sunlamps — banned in minors in many countries

2. Chemoprevention

Nicotinamide (Vitamin B3): 500 mg twice daily — RCT evidence shows 23% reduction in new NMSC in high-risk patients (immunocompetent, history of NMSC)
Acitretin (oral retinoid): First-line chemoprevention in organ transplant recipients; reduces SCC incidence
Vismodegib/Sonidegib (Hedgehog pathway inhibitors): Chemoprevention for patients with Gorlin syndrome (>3 BCCs/year)
Topical 5-FU or imiquimod: Treatment of actinic keratoses to prevent progression to invasive SCC
Topical diclofenac 3% gel: For multiple actinic keratoses

3. Public Health & Education

Sun-awareness campaigns (e.g., "Slip, Slop, Slap" — Australia)
School-based sun protection programmes
Workplace policies for outdoor workers

IV. EARLY DETECTION

A. ABCDE Criteria for Melanoma

The most widely used screening mnemonic for clinical assessment of pigmented lesions:

Letter	Criterion	Significance
A	Asymmetry	One half unlike the other
B	Border irregularity	Notched, scalloped, poorly defined margins
C	Colour variegation	Multiple shades — tan, brown, black, red, white, blue
D	Diameter >6 mm	Larger than a pencil eraser
E	Evolving	Change in size, shape, colour, or new symptom (bleeding, itching)

A changing or newly acquired nevus after age 20 is the most common warning sign for melanoma. Symptoms of bleeding, ulceration, and pain are later signs.

B. The "Ugly Duckling" Sign

A lesion that looks distinctly different from the patient's other nevi — regardless of ABCDE criteria — should be biopsied. Particularly useful for nodular melanoma which may not fulfil ABCDE criteria.

C. Dermoscopy (Epiluminescence Microscopy)

Non-invasive optical technique using magnification (×10–40) + immersion oil or polarised light
Makes subsurface structures visible — increases diagnostic accuracy from ~70% to >90% in trained hands
Melanoma-specific patterns: Atypical pigment network, regression structures, irregular dots/globules, blue-white veil, atypical vascular patterns
BCC-specific patterns: Arborising telangiectasias, leaf-like areas, spoke-wheel areas, blue-grey ovoid nests

D. Clinical Warning Signs for Non-Melanoma Skin Cancer

BCC: Pearly or translucent nodule; non-healing sore; pink growth; scar-like lesion; pink irregular patch
SCC: Non-healing ulcer; persistent rough/scaly patch; raised firm nodule; wart-like growth; persistent actinic keratosis

E. Screening Programmes

Total body skin examination (TBSE): Annual examination by dermatologist for high-risk individuals (organ transplant recipients, personal/family history of melanoma, Gorlin syndrome, >50 nevi, immunosuppressed)
Skin Cancer Foundation guidelines: Monthly self-examination + annual professional examination for all adults
Sentinel lymph node biopsy: Offered for melanoma Breslow depth ≥0.8 mm — staging, not screening

F. Biopsy Principles

Melanoma: Excisional biopsy with 1–2 mm margin (preferred); avoid shave biopsy unless >2 mm depth ensured — Breslow depth is the single most important prognostic indicator
BCC/SCC: Shave or punch biopsy usually adequate for diagnosis
Breslow depth <1 mm: >90% ten-year survival; Breslow depth ≥4 mm carries poor prognosis

G. Diagnostic Adjuncts

Reflectance confocal microscopy (RCM): Near-histological in-vivo imaging; reduces unnecessary biopsies
Multispectral imaging / AI-based dermoscopy tools: Emerging role in high-volume screening settings
Optical coherence tomography (OCT): Useful for BCC depth assessment before therapy

SUMMARY TABLE

Feature	BCC	SCC	Melanoma
Origin	Basal cells	Keratinocytes	Melanocytes
Frequency	Most common	2nd NMSC	Most lethal
Metastatic potential	Very low	Low–moderate	High
Key risk factor	UV-B, fair skin	UV, HPV, scars	UV, nevi, family hx
Precursor	Actinic keratosis (indirect)	Actinic keratosis	Dysplastic nevus
Early detection tool	Dermoscopy, TBSE	Dermoscopy, biopsy	ABCDE + dermoscopy
Best prognosis indicator	Histologic subtype	Differentiation, margins	Breslow depth

REFERENCES

Fitzpatrick's Dermatology, 9th edition (Goldsmith et al.)
Andrews' Diseases of the Skin, 13th edition
Textbook of Family Medicine, 9th edition (Rakel)
Chang RC et al. The Role of Health Literacy in Skin Cancer Preventative Behavior. J Prev, 2024 [PMID: 39110380]

Examiner's Note: For a 10-mark answer, emphasize the ABCDE criteria, dermoscopy, UV as the unifying risk factor, chemoprevention in high-risk groups, and the prognostic importance of Breslow depth in melanoma. Include clinical photographs descriptions in viva-voce settings.

chronic benign familial pemphigus in 5marks format for 3rd yr dermatology post graduate theory examination

Finding Sources

Reading File

Finding Sources

Searching Images

Hailey-Hailey disease familial benign chronic pemphigus clinical histology

Reading File

Loading Image

I now have all the information needed. Here is the complete 5-mark PG examination answer:

Chronic Benign Familial Pemphigus (Hailey-Hailey Disease)

A 5-Mark Dermatology PG Theory Examination Answer

DEFINITION & INTRODUCTION

Chronic benign familial pemphigus (Hailey-Hailey Disease / HHD; OMIM #169600) is a rare autosomal dominant genodermatosis characterised by recurrent, relapsing vesiculobullous and erosive lesions predominantly at intertriginous (friction-bearing) sites. It was first described in 1939 by the Hailey brothers (Howard and Hugh Hailey) at Emory University, who reported the condition in two sets of brothers. The name "pemphigus" is a misnomer — HHD has no autoimmune basis and no circulating antibodies; it is a primary acantholytic genodermatosis.

ETIOPATHOGENESIS & GENETICS

Feature	Detail
Inheritance	Autosomal dominant; complete penetrance; variable expressivity
Gene mutation	ATP2C1 (chromosome 3q21-q24)
Protein affected	hSPCA1 — a Golgi-associated Ca²⁺/Mn²⁺ ATPase
Mechanism	Haploinsufficiency → impaired Ca²⁺ sequestration within Golgi lumen → abnormal intracellular Ca²⁺ signaling → loss of desmosomal adhesion → acantholysis of the spinous layer
New mutations	~30% of cases represent de novo mutations (no positive family history)

Key molecular note: Unlike pemphigus vulgaris (anti-desmoglein antibodies), HHD results from a primary structural failure of calcium-mediated cell adhesion. Heat, sweating, friction and infection all worsen adhesion failure, explaining clinical triggers.

Segmental variants:

Type 1 mosaicism — postzygotic ATP2C1 mutation; localised HHD along Blaschko's lines
Type 2 mosaicism — severe linear involvement superimposed on symmetrical HHD

CLINICAL FEATURES

Age of onset: Late teens to early twenties (2nd–4th decades) Incidence: At least 1 in 50,000 (likely underestimated due to frequent misdiagnosis)

Skin Lesions

Hailey-Hailey disease — macerated erythematous plaques with linear fissuring in the groin

Fig: Hailey-Hailey disease — macerated, erythematous plaques with linear/reticulate fissuring (rhagades) at the groin — Andrews' Diseases of the Skin

Characteristic morphology:

Intact blisters are rarely seen (extremely fragile; rupture immediately)
Macerated, weeping erosions with crusting; linear or reticulate pattern of fissuring (rhagades)
Expanding annular plaques with peripheral scaling
Vegetating plaques in chronic/hypertrophic lesions — resembling impetigo or pemphigus vegetans
Post-inflammatory hyperpigmentation — very common

Predilection sites (friction/intertriginous areas):

Axillae (most common), groins, perineum, perianal region
Sides of neck, inframammary folds
Antecubital fossae, popliteal fossae
Rarely: oral mucosa, oesophagus, labia majora, conjunctiva

Nail sign: Longitudinal white leukonychia (white bands) in fingernails — uncommon but highly specific; useful clue to diagnosis

Symptoms: Pruritus, pain, malodour (secondary infection), regional lymphadenopathy

Aggravating/Triggering Factors

Heat, sweating, friction, tight clothing
Sunburn / UV irradiation
Secondary bacterial infection (S. aureus), candidal or herpetic superinfection
Scabies infestation, contact dermatitis
Koebner phenomenon — lesions develop at sites of trauma or inflammatory dermatoses

Clinical Course

Chronic, relapsing-remitting; worse in summer. May improve with age in some patients. Even mild disease significantly reduces quality of life. The disease does not resolve spontaneously.

HISTOPATHOLOGY

The hallmark is full-thickness acantholysis — described as the "dilapidated brick wall" appearance.

Feature	Description
Full-thickness acantholysis	Widespread loss of intercellular bridges throughout the spinous layer ("dilapidated brick wall")
Villi formation	Dermal papillae lined by a single layer of basal cells protrude into blister cavities
Dyskeratosis	Mild; far less prominent than in Darier disease; rare corps ronds or grains
Suprabasal clefting	Intraepidermal vesicle/bulla formation
Dermal infiltrate	Moderate perivascular lymphocytic infiltrate in superficial dermis
Chronic lesions	Epidermal hyperplasia, parakeratosis, focal crusts

Immunofluorescence:

Direct IF (DIF) — NEGATIVE (no immunoglobulins or complement in epidermis)
Indirect IF — NEGATIVE
This critically distinguishes HHD from pemphigus vulgaris (IgG intercellular deposits)

DIFFERENTIAL DIAGNOSIS

Condition	Distinguishing Feature
Darier disease (DD)	Corps ronds & grains prominent; ATP2A2 mutation; nail V-notches; follicular keratotic papules; acrokeratosis verruciformis
Pemphigus vulgaris	Positive DIF (IgG intercellular); oral involvement early; anti-desmoglein 3 antibodies
Pemphigus vegetans	Positive DIF; no family history; vegetating oral lesions
Intertrigo / Candidiasis	No acantholysis on biopsy; responds to antifungals; no family history
Inverse psoriasis	Sharper borders; less erosion/crusting; nail pitting; positive family history of psoriasis
Grover disease	Histologically identical but clinically distinct — acute onset, trunk, elderly males, no family history
Herpes simplex (HSV)	Tzanck smear positive; DIF with HSV antigen; responds to acyclovir

TREATMENT

General Measures (First Line)

Minimise friction and sweating; lightweight, loose clothing
Antiseptic cleansers/bleach baths
Avoid adhesive dressings and known triggers
Topical antimicrobials (clindamycin, mupirocin) + topical antifungals to control secondary infection
Moderately potent topical corticosteroids combined with antimicrobials

Second Line

Ultrapotent topical corticosteroids (with caution in intertriginous areas — risk of striae, atrophy)
Oral prednisolone 20–30 mg/day, tapered — for acute exacerbations
Oral systemic antibiotics against S. aureus (tetracycline, minocycline)

Third Line (Refractory / Severe Disease)

Agent	Mechanism/Role
Botulinum toxin A	Reduces sweating in flexural areas; highly effective for axillary disease
Oral cyclosporine 2.5 mg/kg	Anti-inflammatory; useful for widespread disease
Oral retinoids (acitretin)	Normalises keratinisation; start at low dose
Methotrexate 10–15 mg/week	Anti-proliferative; useful in recalcitrant cases
Topical tacrolimus	Calcineurin inhibitor; steroid-sparing
Topical 5-fluorouracil	Antiproliferative; reduces lesion burden
Topical vitamin D analogues (calcitriol, tacalcitol)	Modulate calcium signalling
NB-UVB phototherapy	Anti-inflammatory
Photodynamic therapy (PDT)	Useful for recalcitrant localised lesions
Dapsone	Anti-inflammatory; some evidence of benefit
Low-dose naltrexone	Recently reported for pruritus relief
Dupilumab	Emerging; JAK inhibitors also under evaluation

Surgical/Ablative (Severe Refractory Cases)

CO₂ laser vaporisation / dermabrasion — destroys affected epidermis; heals from uninvolved adnexal structures; long-lasting remission
Surgical excision + grafting — most severe cases
Reduction mammoplasty — for severe, refractory inframammary disease
Electron beam therapy — rare, extreme cases

SUMMARY POINTS FOR VIVA

Key Fact	Detail
Gene	ATP2C1 (Golgi Ca²⁺ ATPase — hSPCA1)
Inheritance	Autosomal dominant
Pathology	Full-thickness acantholysis — "dilapidated brick wall"
Differs from DD	ATP2C1 vs ATP2A2; less dyskeratosis; negative DIF
DIF	Negative (no antibodies — NOT an autoimmune disease)
Nikolsky sign	Positive (acantholysis)
Nail sign	Longitudinal leukonychia (white bands)
Best surgical Rx	CO₂ laser / dermabrasion
Unique treatment	Botulinum toxin A for axillary disease

References:

Andrews' Diseases of the Skin, 13th ed., p. 650
Fitzpatrick's Dermatology, 9th ed. (Goldsmith et al.), Chapter 50
Dermatology, 5th ed. (Bolognia et al.), Chapter 59

chronic benign familial pemphigus in 5marks format for 3rd yr dermatology post graduate theory examination

The complete answer was already provided just above. Here it is reproduced cleanly for your reference:

Chronic Benign Familial Pemphigus (Hailey-Hailey Disease)

5-Mark Dermatology PG Theory Examination Answer

DEFINITION & INTRODUCTION

Chronic benign familial pemphigus (Hailey-Hailey Disease / HHD; OMIM #169600) is a rare autosomal dominant genodermatosis characterised by recurrent, relapsing vesiculobullous and erosive lesions predominantly at intertriginous (friction-bearing) sites. Described in 1939 by Howard and Hugh Hailey at Emory University in two sets of brothers. The name "pemphigus" is a misnomer — HHD has no autoimmune basis, no circulating antibodies; it is a primary acantholytic genodermatosis.

ETIOPATHOGENESIS & GENETICS

Feature	Detail
Inheritance	Autosomal dominant; complete penetrance; variable expressivity
Gene	ATP2C1 (chromosome 3q21-q24)
Protein	hSPCA1 — Golgi-associated Ca²⁺/Mn²⁺ ATPase
Mechanism	Haploinsufficiency → impaired Ca²⁺ sequestration in Golgi → defective desmosomal adhesion → acantholysis of spinous layer
De novo mutations	~30% of patients; no positive family history in these cases

Segmental variants:

Type 1 mosaicism — postzygotic ATP2C1 mutation; localised HHD along Blaschko's lines
Type 2 mosaicism — severe linear disease superimposed on symmetrical HHD

Unlike pemphigus vulgaris (anti-desmoglein antibodies), HHD is a structural failure of calcium-mediated keratinocyte cohesion. Heat, sweating, friction and infection all worsen acantholysis.

CLINICAL FEATURES

Age of onset: Late teens to early twenties (2nd–4th decades) Incidence: ≥1 in 50,000 (likely underestimated — frequently misdiagnosed as eczema or intertrigo)

Morphology

Intact blisters are rarely visible (extremely fragile; rupture at once). Lesions instead present as:

Macerated, weeping erosions with crusting
Linear/reticulate fissuring (rhagades) — pathognomonic pattern
Expanding annular plaques with peripheral scaling
Vegetating/hypertrophic plaques in chronic lesions (resembles pemphigus vegetans)
Post-inflammatory hyperpigmentation — very common

Hailey-Hailey disease — macerated erythematous plaques with characteristic linear fissuring in the groin

Hailey-Hailey disease — macerated erythematous erosions with linear fissuring at intertriginous site (Andrews' Diseases of the Skin)

Sites of Predilection (friction/intertriginous)

Axillae (most common) • Groins • Perineum/perianal • Sides of neck • Inframammary folds • Antecubital and popliteal fossae

Rarely: oral mucosa, oesophagus, labia majora

Nail Sign

Longitudinal white leukonychia (white bands on fingernails) — uncommon but highly specific diagnostic clue

Symptoms

Pruritus, pain, malodour (secondary bacterial/fungal infection), regional lymphadenopathy

Triggering/Aggravating Factors

Heat • Sweating • Friction • UV irradiation/sunburn • Secondary infections (S. aureus, Candida, HSV) • Scabies • Contact dermatitis → Koebner phenomenon present

Clinical Course

Chronic, relapsing-remitting; worse in summer; may improve in old age. Does not resolve spontaneously. Even mild disease significantly impairs quality of life.

HISTOPATHOLOGY

Hallmark: Full-thickness acantholysis — the classic "dilapidated brick wall" appearance

Feature	Description
Full-thickness acantholysis	Widespread loss of intercellular bridges throughout entire spinous layer — "dilapidated brick wall"
Villi	Dermal papillae lined by a single basal cell layer projecting into the blister cavity
Dyskeratosis	Mild; occasional acantholytic dyskeratotic cells (rare corps ronds); far less prominent than Darier disease
Suprabasal clefting	Intraepidermal vesicle/bulla formation
Dermal infiltrate	Moderate perivascular lymphocytic infiltrate in superficial dermis
Chronic lesions	Epidermal hyperplasia, parakeratosis, focal crusts

Immunofluorescence

Test	Result	Significance
Direct IF (DIF)	NEGATIVE	No IgG/IgM/complement in epidermis — rules out pemphigus vulgaris
Indirect IF	NEGATIVE	No circulating antibodies

DIFFERENTIAL DIAGNOSIS

Condition	Key Distinguishing Feature
Darier disease (DD)	ATP2A2 mutation; corps ronds & grains prominent; nail V-notches; follicular keratotic papules on seborrhoeic areas
Pemphigus vulgaris	DIF positive (IgG intercellular); anti-desmoglein 3 antibodies; prominent oral involvement
Pemphigus vegetans	DIF positive; vegetating oral lesions; no family history
Intertrigo/Candidiasis	No acantholysis on biopsy; responds to antifungals; no family history
Inverse psoriasis	Sharper borders; less erosion; nail pitting; psoriatic family history
Grover disease	Histologically identical but clinically distinct: acute onset, trunk, elderly males, no family history
Herpes simplex	Tzanck smear +ve; responds to acyclovir; Multinucleate giant cells on histology

TREATMENT

First Line (General Measures)

Minimise friction/sweating; loose, lightweight clothing; avoid adhesive dressings
Antiseptic cleansers / bleach baths
Topical antimicrobials (clindamycin, mupirocin) + topical antifungals — address secondary infection
Moderately potent topical corticosteroids + topical antimicrobials

Second Line

Ultrapotent topical corticosteroids (use with caution in flexures — risk of striae/atrophy)
Oral prednisolone 20–30 mg/day tapered — for acute severe flares
Systemic antistaphylococcal antibiotics (tetracycline, minocycline, doxycycline) — long-term low dose

Third Line — Refractory/Severe Disease

Agent	Notes
Botulinum toxin A	Reduces sweating; highly effective for axillary HHD; induces prolonged remission
Oral cyclosporine 2.5 mg/kg	Anti-inflammatory; for widespread disease
Oral retinoids (acitretin)	Start low dose; minimise irritation
Methotrexate 10–15 mg/week	Anti-proliferative; useful in recalcitrant cases
Topical tacrolimus	Calcineurin inhibitor; steroid-sparing
Topical 5-fluorouracil	Antiproliferative
Topical vitamin D analogues (calcitriol, tacalcitol)	Modulate Ca²⁺ signalling
NB-UVB phototherapy	Anti-inflammatory
Photodynamic therapy (PDT)	Localised refractory lesions
Dapsone	Anti-inflammatory; some evidence
Low-dose naltrexone	Pruritus relief
Dupilumab / JAK inhibitors	Emerging evidence

Surgical (Most Severe/Refractory)

CO₂ laser vaporisation / dermabrasion — destroys affected epidermis; heals from uninvolved adnexal structures; most effective surgical option with prolonged remission
Surgical excision + skin grafting — extreme cases
Reduction mammoplasty — severe inframammary disease
Electron beam therapy — rarely needed

HIGH-YIELD VIVA SUMMARY

Key Point	Answer
Gene mutated	ATP2C1
Protein affected	hSPCA1 (Golgi Ca²⁺ ATPase)
Inheritance	Autosomal dominant
Histological hallmark	"Dilapidated brick wall" — full-thickness acantholysis
Differs from Darier disease	ATP2C1 vs ATP2A2; less dyskeratosis; no corps ronds; negative DIF
Differs from pemphigus vulgaris	DIF negative; no antibodies; autosomal dominant; not autoimmune
Nikolsky sign	Positive (epidermal acantholysis)
Specific nail sign	Longitudinal leukonychia (white bands)
Best unique treatment	Botulinum toxin A (axillary disease)
Best surgical option	CO₂ laser / dermabrasion

References:

Andrews' Diseases of the Skin, 13th ed., p. 650
Fitzpatrick's Dermatology, 9th ed. (Goldsmith et al.), Chapter 50
Dermatology, 5th ed. (Bolognia, Schaffer & Cerroni), Chapter 59

Blau syndrome in 5marks format for 3rd yr dermatology post graduate theory examination

Finding Sources

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.